Open AccessComparison of Different Methods for Defining Hyperprogressive Disease in NSCLC
Author(s) -
Pedro Rocha,
Didac Ramal,
Enric Ripoll,
Laura Moliner,
Alex Corbera,
Max Hardy-Werbin,
Mayra Orrillo,
Álvaro Taus,
Flavio Zuccarino,
Joan Gibert,
Júlia Perera-Bel,
David Casadevall,
Edurne Arriola
Publication year - 2020
Publication title -
jto clinical and research reports
Language(s) - English
Resource type - Journals
ISSN - 2666-3643
DOI - 10.1016/j.jtocrr.2020.100115
Subject(s) - medicine , docetaxel , nivolumab , concordance , cohort , oncology , incidence (geometry) , response evaluation criteria in solid tumors , nuclear medicine , disease , progressive disease , chemotherapy , cancer , immunotherapy , mathematics , geometry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom